Is Semaglutide Cost-Effective for the Secondary Prevention of Cardiovascular Disease in People with Overweight or Obesity in Australia?

Autor: Zomer, E., Zhou, J., Nelson, A., Nicholls, S., Stub, D., Zoungas, S.
Zdroj: In Heart, Lung and Circulation August 2024 33 Supplement 4:S523-S523
Databáze: ScienceDirect